📰 Biocon Ceo News
Biocon Ceo News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Biocon Ceo. Real-time updates on events, politics, business and more.
September 20, 2023
"Every one of our individual businesses is at an inflection point of high growth. Peter Bains, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon Group because he has basically played a very key role in Syngene. Through Syngene, he has understood the entire Biocon business very well."
September 20, 2023
"Peter, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon Group because he has basically played a very key role in Syngene. Through Syngene, he has understood the entire Biocon business very well."
September 18, 2023
He has over 30 years of global experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on the Board of Syngene International Ltd, a subsidiary of the company, for almost 6 years from 2010, and led the company to its successful public listing in 2015, Biocon said.
August 18, 2023
Biosimilars have led the growth in the April-June 2023 period and will continue to do so. The company also hopes to capitalise on its already strong presence in the US market, and stay ahead of the competition in the Indian market.